Skip to main content

Table 3 Blood biomarkers and quality of life (mean ± SD) following 12 weeks of Active-at-Home-HF

From: Acceptability, Feasibility and Preliminary Evaluation of a Novel, Personalised, Home-Based Physical Activity Intervention for Chronic Heart Failure (Active-at-Home-HF): a Pilot Study

 

Pre-intervention

Post-intervention

P value

% change

Cholesterol (mmol/l)

4.0 ± 0.9

3.9 ± 0.9

0.59

2.5

Triglyceride (mmol/l)

1.5 ± 0.7

1.8 ± 0.9

0.45

20

HDL (mmol/l)

1.2 ± 0.3

1.1 ± 0.3

0.67

8.3

LDL (mmol/l)

2.1 ± 0.7

1.9 ± 0.7

0.46

9.5

HbA1c (mmol/mol)

49.2 ± 17.3

47.5 ± 12

0.77

3.5

FBG (mmol/l)

6.2 ± 2.9

7.0 ± 3.8

0.56

12.9

NT proBNP (pg/ml)

823 ± 1085

876 ± 1114

0.89

6.4

Renal function eGFR

65.4 ± 18.6

61.4 ± 17.4

0.61

6.1

QoL

26 ± 18

22 ± 23

0.50

15.4

  1. HDL high-density lipoprotein, LDL low-density lipoprotein, HBA1c glycated haemoglobin, FBG fasting blood glucose, NT proBNP N-terminal brain natriuretic peptide, QoL quality of life, eGFR glomerular filtration rate